A monthly, SKU-level read on the U.S. body trimmer category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing, and positioning calls.
...Read More »August 31, 2026
The global spinal muscular atrophy (SMA) drugs market was valued at USD 5.4B in 2025 and is projected to expand at a CAGR of 3.7% from 2026 to 2033. Competition is driven primarily by treatment modality rather than branded versus generic products, as all three therapies remain under patent. Zolgen...Read More »
August 28, 2026
A monthly, SKU-level read on the U.S. body lotion category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing, and positioning calls.
...Read More »August 27, 2026
A monthly, SKU-level read on the U.S. body mist category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing, and positioning calls.
...Read More »August 27, 2026
The global neuropathic pain drugs market was valued at USD 6.8B in 2025 and is projected to expand at a CAGR of 7.3% from 2026 to 2033. The market is evolving from a mature, generic-driven landscape toward the adoption of novel non-opioid therapies. Suzetrigine (Vertex Pharmaceuticals) is leading ...Read More »
August 27, 2026
The global ovarian cancer drugs market was valued at USD 2.3B in 2025 and is projected to reach USD 4.1B by 2033, at a CAGR of 7.2% during the forecast period from 2026 to 2033. The market growth is driven by the introduction of first-in-class targeted therapies for a biomarker-defined patient pop...Read More »
August 26, 2026
The global Parkinson's drugs market was valued at USD 3.7B in 2025 and is projected to reach USD 7.2B by 2033, expanding at a CAGR of 8.5%. The market is gradually shifting from mature, generic dopaminergic therapies toward premium formulations, continuous dopaminergic delivery systems, and specia...Read More »
August 26, 2026
A monthly, SKU-level read on the U.S. body oil category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing, and positioning calls.
...Read More »August 26, 2026
A monthly, SKU-level read on the U.S. bath bombs category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing, and positioning calls
...Read More »August 25, 2026
A monthly, SKU-level read on the U.S. brain health supplements category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing and positioning calls.
...Read More »August 25, 2026
A monthly, SKU-level read on the U.S. berberine supplements category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing and positioning calls.
...Read More »August 25, 2026
A monthly, SKU-level read on the U.S. sleep support supplements category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing and positioning calls.
...Read More »August 24, 2026
A monthly, SKU-level read on the U.S. anti-aging supplements category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing and positioning calls.
...Read More »August 24, 2026
A monthly, SKU-level read on the U.S. aftershave category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing, and positioning calls.
...Read More »August 24, 2026
GVR's database covers 17 commercially marketed colorectal cancer drugs, which generated an estimated USD 10.1B in 2025 and are projected to generate USD 15.3B in 2033, growing at a CAGR of 5.6% from 2026 to 2033. Recent regulatory approvals continue to expand treatment options in the colorectal ca...Read More »
August 20, 2026
A monthly, SKU-level read on the U.S. pre-workout supplements category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing and positioning calls.
...Read More »August 20, 2026
The global pancreatic cancer drugs market was valued at USD 0.5B in 2025 and is projected to remain a stable USD 0.6B by 2033. This analysis covers 5 leading marketed drugs for pancreatic cancer. Abraxane (paclitaxel protein-bound particles for injectable suspension) was approved by the U.S. FDA i...Read More »
August 20, 2026
The global gastric cancer drugs market was valued at approximately USD 3.8B in 2025 and is projected to reach USD 5.8B by 2033, growing at a CAGR of 4.4%. This analysis covers 15 leading marketed drugs for gastric malignancy, highlighting the industry's transition toward biomarker-driven treatment...Read More »
August 19, 2026
The global multiple sclerosis drugs market was valued at USD 31.8B in 2025 and is projected to reach USD 59.6B by 2033, growing at a CAGR of 8.0%. Market growth is increasingly driven by a shift from conventional injectable and oral disease-modifying therapies (DMTs) toward high-efficacy biologics...Read More »
August 17, 2026
A monthly, SKU-level read on the U.S. fiber supplements category on Amazon - engineered to show where category revenue sits and how to compete for it. 8 tracked KPIs turn raw marketplace signals into decision-grade data for product, pricing and positioning calls.
...Read More »August 13, 2026
Tell us what you need. We reply within one working day.
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.